Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Research Article

A comparative in vivo Evaluation of Anti-Alzheimer Activity of Bacopa Extract and its Solid Lipid Nanoparticles

Author(s): Rajesh Kumar, Rajeev Garg* and Navneet Khurana

Volume 17, Issue 7, 2021

Published on: 13 November, 2020

Article ID: e010621187982 Pages: 11

DOI: 10.2174/1573407216999201113121756

Price: $65

Abstract

Background: Bacopa monnieri (Brahmi; family Scrophulariaceae) is a well-known plant known for its nootropic activity. Delivery of Bacosides (an active constituent) is limited at the site of action owing to the existence of the Blood-Brain Barrier (BBB). In order to take the Bacoside- Rich Extract (BRE) across BBB, formulated solid lipid nanoparticles (SLNs) were used.

Objective: The objective of this work was to evaluate the pharmacokinetic and pharmacodynamic behavior (in vivo potential) of the prepared SLNs containing BRE in comparison to BRE alone for the treatment of Alzheimer’s disease.

Methods: Swiss albino male mice (25-30 gm) were used for the study. The pharmacokinetic, as well as pharmacodynamic evaluation of formulated SLNs, were performed in comparison to BRE in a scopolamine-induced amnesia model.

Results: BRE-loaded SLNs were found to be significantly more effective than BRE in alleviating neurodegeneration. The pharmacokinetic study revealed the improved bioavailability of prepared SLNs with the potential of sustaining the drug release in mice for an extended period of time.

Conclusion: The results demonstrated that the SLNs can be considered as a potential delivery system for taking BRE across the BBB to treat Alzheimer’s disease.

Keywords: Bacoside, solid lipid nanoparticles, blood brain barrier, alzheimer’s disease, pharmacokinetics, pharmacodynamics.

Graphical Abstract
[1]
Guarnieri, G.; Sarchielli, E.; Vannelli, G.B.; Morelli, A. Cell-based therapy in Alzheimer’s disease: Can human fetal cholinergic neurons “untangle the skein”? Neural Regen. Res., 2018, 13(12), 2105-2107.
[http://dx.doi.org/10.4103/1673-5374.241459] [PMID: 30323137]
[2]
Burke, A.D.; Goldfarb, D.; Bollam, P.; Khokher, S. Diagnosing and treating depression in patients with alzheimer’s disease. Neurol. Ther., 2019, 8(2), 325-350.
[http://dx.doi.org/10.1007/s40120-019-00148-5] [PMID: 31435870]
[3]
Williams, J.W.; Plassman, B.L.; Burke, J.; Benjamin, S.; Benjamin, S. Preventing Alzheimer’s disease and cognitive decline. Evid. Rep. Technol. Assess. (Full. Rep), 2010, 193(193), 1-727.
[PMID: 21500874]
[4]
Mesulam, M.M. The cholinergic innervation of the human cerebral cortex. Prog. Brain Res., 2004, 145, 67-78.
[http://dx.doi.org/10.1016/S0079-6123(03)45004-8] [PMID: 14650907]
[5]
Blokland, A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Brain Res. Rev., 1995, 21(3), 285-300.
[http://dx.doi.org/10.1016/0165-0173(95)00016-X] [PMID: 8806017]
[6]
Blokland, A.; Schreiber, R.; Prickaerts, J. Improving memory: a role for phosphodiesterases. Curr. Pharm. Des., 2006, 12(20), 2511-2523.
[http://dx.doi.org/10.2174/138161206777698855] [PMID: 16842174]
[7]
Hostettmann, K.; Marston, A.; Maillard, M.; Hamburger, M. Phytochemistry of plants used in traditional medicine., 1995.
[8]
Sparg, S.G.; Light, M.E.; van Staden, J. Biological activities and distribution of plant saponins. J. Ethnopharmacol., 2004, 94(2-3), 219-243.
[http://dx.doi.org/10.1016/j.jep.2004.05.016] [PMID: 15325725]
[9]
Koczurkiewicz, P.; Kowolik, E.; Podolak, I.; Wnuk, D.; Piska, K.; Łabędź-Masłowska, A.; Wójcik-Pszczoła, K.; Pękala, E.; Czyż, J.; Michalik, M. Synergistic ctotoxic and anti-invasive effects of mitoxantrone and triterpene saponins from lysimachia ciliata on human prostate cancer cells. Planta Med., 2016, 82(18), 1546-1552.
[http://dx.doi.org/10.1055/s-0042-117537] [PMID: 27737477]
[10]
Gohil, K.J.; Patel, J.A. A review on Bacopa monniera: current research and future prospects. Int. J. Green Pharm., 2010, 4(1) [IJGP].
[http://dx.doi.org/10.4103/0973-8258.62156]
[11]
Prasad, R.; Bagde, U.; Pushpangadan, P.; Varma, A. Bacopa monniera L: pharmacological aspects and case study involving Piriformospora indica. Int. J. Integr. Biol., 2008, 3(2), 100-110.
[12]
Sekhar, V.C.; Viswanathan, G.; Baby, S. Insights into the molecular aspects of neuroprotective bacoside A and bacopaside I. Curr. Neuropharmacol., 2019, 17(5), 438-446.
[http://dx.doi.org/10.2174/1570159X16666180419123022] [PMID: 29676230]
[13]
Debarshi, K.M.; Shailendra, P.; Asmita, G.P. The progressive journey of phytosomes in herbal based pharmacotherapeutics. Curr. Bioact. Compd., 2020, 16(6), 853-886.
[14]
Russo, A.; Izzo, A.A.; Borrelli, F.; Renis, M.; Vanella, A. Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother. Res., 2003, 17(8), 870-875.
[http://dx.doi.org/10.1002/ptr.1061] [PMID: 13680815]
[15]
Muntoni, E.; Martina, K.; Marini, E.; Giorgis, M.; Lazzarato, L.; Salaroglio, I.C.; Riganti, C.; Lanotte, M.; Battaglia, L. Methotrexate-loaded solid lipid nanoparticles: Protein functionalization to improve brain biodistribution. Pharmaceutics, 2019, 11(2), 65.
[http://dx.doi.org/10.3390/pharmaceutics11020065] [PMID: 30717376]
[16]
Naseri, N.; Valizadeh, H.; Zakeri-Milani, P. Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv. Pharm. Bull., 2015, 5(3), 305-313.
[http://dx.doi.org/10.15171/apb.2015.043] [PMID: 26504751]
[17]
Bayón-Cordero, L.; Alkorta, I.; Arana, L. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials (Basel), 2019, 9(3), 474.
[http://dx.doi.org/10.3390/nano9030474] [PMID: 30909401]
[18]
Kumar, R.; Singh, T.; Kumar, D.; Singh, M.; Kaur, S.; Garg, R. Estimation of bacoside-A in bacopa monnieri aerial parts using TLC densitometry. Int. J. Pharm. Pharm. Sci., 2015, 7(12), 293-295.
[19]
Kumar, R.; Garg, R. Formulation and evaluation of solid lipid nanoparticles loaded with bacoside rich extract. Int. J. Pharm. Sci. Res., 2020, 11(1), 371-377.
[20]
Kumar, R.; Garg, R. Bacoside rich extract loaded Solid Lipid Nanoparticles for Alzheimer’s disease. Plant Arch., 2020, 20(1), 247-252.
[21]
Jyoti, A.; Sharma, D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology, 2006, 27(4), 451-457.
[http://dx.doi.org/10.1016/j.neuro.2005.12.007] [PMID: 16500707]
[22]
Kumar, N.; Abichandani, L.; Thawani, V.; Gharpure, K.; Naidu, M.; Venkat Ramana, G. Efficacy of standardized extract of Bacopa monnieri (Bacognize®) on cognitive functions of medical students: a six-week, randomized placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine, 2016.
[23]
Misra, S.; Chopra, K.; Sinha, V.R.; Medhi, B. Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations. Drug Deliv., 2016, 23(4), 1434-1443.
[http://dx.doi.org/10.3109/10717544.2015.1089956] [PMID: 26405825]
[24]
Khurana, N.; Ishar, M.P.; Gajbhiye, A.; Goel, R.K. PASS assisted prediction and pharmacological evaluation of novel nicotinic analogs for nootropic activity in mice. Eur. J. Pharmacol., 2011, 662(1-3), 22-30.
[http://dx.doi.org/10.1016/j.ejphar.2011.04.048] [PMID: 21554868]
[25]
Parle, M.; Vasudevan, M. Memory enhancing activity of Abana®: an Indian ayurvedic poly-herbal formulation. J. Health Sci., 2007, 53(1), 43-52.
[http://dx.doi.org/10.1248/jhs.53.43]
[26]
Habibyar, A.F.; Sharma, N.; Khurana, N. PASS assisted prediction and pharmacological evaluation of hesperidin against scopolamine induced amnesia in mice. Eur. J. Pharmacol., 2016, 789, 385-394.
[http://dx.doi.org/10.1016/j.ejphar.2016.07.013] [PMID: 27397428]
[27]
Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 1984, 11(1), 47-60.
[http://dx.doi.org/10.1016/0165-0270(84)90007-4] [PMID: 6471907]
[28]
Davoodi, F.G.; Motamedi, F.; Naghdi, N.; Akbari, E. Effect of reversible inactivation of the reuniens nucleus on spatial learning and memory in rats using Morris water maze task. Behav. Brain Res., 2009, 198(1), 130-135.
[http://dx.doi.org/10.1016/j.bbr.2008.10.037] [PMID: 19038291]
[29]
Bromley-Brits, K.; Deng, Y.; Song, W. Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J. Vis. Exp., 2011, (53), e2920.
[http://dx.doi.org/10.3791/2920] [PMID: 21808223]
[30]
Vorhees, C.V.; Williams, M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc., 2006, 1(2), 848-858.
[http://dx.doi.org/10.1038/nprot.2006.116] [PMID: 17406317]
[31]
Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 1979, 95(2), 351-358.
[http://dx.doi.org/10.1016/0003-2697(79)90738-3] [PMID: 36810]
[32]
Beutler, E.; Duron, O.; Kelly, B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 1963, 61, 882-888.
[PMID: 13967893]
[33]
Aebi, H. Catalase in vitro.Methods in enzymology; Elsevier, 1984, Vol. 105, pp. 121-126. [13]
[34]
Bisswanger, H. Practical Enzymology.Wiley-YCH Verlag GmbH&Co KGaA, Weinheim, 2004.
[35]
Ellman, G.L.; Courtney, K.D.; Andres, V., Jr; Feather-Stone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 1961, 7(2), 88-95.
[http://dx.doi.org/10.1016/0006-2952(61)90145-9] [PMID: 13726518]
[36]
Goverdhan, P.; Sravanthi, A.; Mamatha, T. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int. J. Alzheimers Dis., 2012, 2012, 974013.
[http://dx.doi.org/10.1155/2012/974013] [PMID: 22536538]
[37]
Abd-El-Fattah, M.A.; Abdelakader, N.F.; Zaki, H.F. Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats. Eur. J. Pharmacol., 2014, 723, 330-338.
[http://dx.doi.org/10.1016/j.ejphar.2013.11.008] [PMID: 24315930]
[38]
Mosanezhad Jeddi, E.; Nazari, M.A. Effectiveness of EEG-biofeedback on attentiveness, working memory and quantitative electroencephalography on reading disorder. Iran. J. Psychiatry. Behav. Sci., 2013, 7(2), 35-43.
[PMID: 24644508]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy